Jeffery Cohen is the Director of the Experimental Therapeutics Program and the Clinical Neuroimmunology Fellowship at the Mellen Center for Multiple Sclerosis Treatment and Research at the Cleveland Clinic. He is one of the top global multiple sclerosis KOLs. He has extensive experience in MS clinical trials, especially in the cell therapy field. In addition to his large clinical practice devoted primarily to the care of patients with multiple sclerosis (MS) and related disorders, Dr. Cohen has been involved in a large number of clinical trials investigating potential new therapies for MS, especially in cell therapy field. A world-renowned expert on MS, Dr. Cohen has served on a large number of grant review committees, advisory groups, and national and international task forces.
This person is not in the org chart